Riociguat and sildenafil attenuate secondary pulmonary hypertension in a model of left heart failure

K. Pradhan

An abstract presentation by K. Pradhan at the 7th PVRI Workshops and Debates Conference in Bad Nauheim, Germany, January 27-31st 2014.

Additional key-words: riociguat,sildenafil,secondary PH,

Latest PVD abstracts from PubMed

The Influence of Laser Modification on a Composite Substrate and the Resistance of Thin Layers Created using the PVD Process.

Authors: Korzeniewska E, Tomczyk M, Walczak M Source: Sensors (Basel)

Clinical Characteristics and Histopathology of Idiopathic Epiretinal Membrane in Vietnam.

Authors: Ngan ND, Cuong NV, Trung NL, Dat DT, Tuan HA, Dong PN, Nga VT, Bac ND, Xuan CL Source: Open Access Maced J Med Sci

Optical coherence tomography angiography as a novel approach to contactless evaluation of sublingual microcirculation: A proof of principle study.

Authors: Hessler M, Nelis P, Ertmer C, Alnawaiseh M, Lehmann F, Schmidt C, Kampmeier TG, Rehberg SW, Arnemann PH, Rovas A Source: Sci Rep

Features of the Vaginal and Vestibular Microbioma in Patients With Vestibulodynia: A Case-Control Study.

Authors: Murina F, Caimi C, Di Pierro F, Di Francesco S, Cetin I Source: J Low Genit Tract Dis

Safety and immunogenicity of fully liquid and lyophilized formulations of an investigational trivalent group B streptococcus vaccine in healthy non-pregnant women: Results from a randomized comparative phase II trial.

Authors: Beran J, Leroux-Roels G, Van Damme P, de Hoon J, Vandermeulen C, Al-Ibrahim M, Johnson C, Peterson J, Baker S, Seidl C, Dreisbach A, Karsten A, Corsaro B, Henry O, Lattanzi M, Bebia Z Source: Vaccine

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI

Related Content

{{GlobalController.truncateTitle("Clinical evaluation of the RV-PA interaction using pulmonary vascular impedance and pressure-volume loops", 65)}}

{{GlobalController.truncateTitle("Right ventricular systolic pressure (RVSP) of hypoxic mutant (D849N) mice receiving imatinib.", 65)}}

{{GlobalController.truncateTitle("Right ventricular hypertrophy in hypoxic mutant (D849N) mice receiving imatinib", 65)}}

{{GlobalController.truncateTitle("Muscularization of pulmonary vessels in hypoxic mutant (D849N) mice receiving imatinib", 65)}}

{{GlobalController.truncateTitle("HJ Bogaard: The Most Important Target of Therapy in Advanced WHO Category 1 Pulmonary Hypertension is the Right Ventricle", 65)}}

Add to reading list

Share this content

Our research platform is the world.